TLX
TelixN/ANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
No composite grade available (requires momentum and value).
Posture
Unrated
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -27.2.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
50
Value
N/A
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade N/A · Unrated
Confidence Medium · Net Neutral
Target $16.67
Why
Momentum50 · Δ7d -27.2
ValueN/A · Δ7d -
SentimentN/A · Δ7d -
So what
Insufficient data coverage. Recheck when scores populate.
Lead driver: Momentum · See technicals
Momentum
50
100% active weight
Current posture
7d trendSoftening
Δ7d
-27.2
Δ21d
-38.0
Value
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
No composite grade available (requires momentum and value).
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$3.08B
Beta
-
Shares Out
337.88M
P/E (TTM) · Derived
-431.6
P/S (TTM)
-
P/FCF (TTM)
-
Rev YoY
-
EPS YoY
-
Gross Margin
-
Op Margin
-
Net Debt
-
Current Ratio
-
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology